StonvexLoading…
StonvexStonvexStonvexCore line items from SNDK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-04-03 | Q1 2026 2026-01-02 | Q4 2025 2025-10-03 | Annual 2025 2025-06-27 |
|---|---|---|---|---|
Revenue | $11.28B | $5.33B | $2.31B | $7.36B |
Operating Income | $5.35B | $1.24B | $176.00M | $-1.38B |
Net Income | $4.53B | $803.00M | $112.00M | $-1.64B |
EPS (Diluted) | $29.42 | $6.02 | $0.75 | $-11.32 |
Total Assets | $17.07B | $13.00B | $12.75B | $12.98B |
Total Liabilities | $3.30B | $2.79B | $3.37B | $3.77B |
Cash & Equivalents | $3.73B | $1.54B | $1.44B | $1.48B |
Free Cash Flow OCF − CapEx | $4.41B | $1.42B | $438.00M | $-120.00M |
Shares Outstanding | 148.00M | 148.00M | 147.00M | 146.00M |